Targeted therapy or transplantation for paediatric ABL-class Ph-like acute lymphocytic leukaemia?

Lancet Haematol. 2020 Dec;7(12):e858-e859. doi: 10.1016/S2352-3026(20)30369-0.
No abstract available

MeSH terms

  • Child
  • Fusion Proteins, bcr-abl / antagonists & inhibitors
  • Fusion Proteins, bcr-abl / genetics*
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Molecular Targeted Therapy*
  • Philadelphia Chromosome*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
  • Prognosis

Substances

  • Fusion Proteins, bcr-abl

Associated data

  • ClinicalTrials.gov/NCT00022737
  • ClinicalTrials.gov/NCT00287105
  • ClinicalTrials.gov/NCT00720109
  • ClinicalTrials.gov/NCT01460160
  • ClinicalTrials.gov/NCT01423747
  • ClinicalTrials.gov/NCT01423500
  • ClinicalTrials.gov/NCT01949129
  • ClinicalTrials.gov/NCT01117441